A new study found that a drug recently approved to treat type 2 diabetes and kidney disease in patients with additional ...

Johnson & Johnson MedTech announced that it intends to resume the rollout of its Varipulse platform in the U.S. after a temporary pause.

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...

People who have a transient ischemic attack (TIA) should get aggressive treatment to help protect cognitive health, a new study suggests.

After adjusting for potential confounders (age, sex, race, use of birth control, pregnancy), findings showed propranolol use was associated with a significant reduction in the risk of stroke among ...

The severity of left ventricular diastolic dysfunction affects risk for incident stroke and transient ischemic attack, as well as major bleeding.

Compared with thrombotic stroke, hemorrhagic stroke has more than double the odds of diagnostic delay in pregnant and postpartum patients.

RapidAI automated imaging appeared to be more accurate than VizAI in detecting cases of large vessel occlusion, as well as in ...

Older age, lower education, and living in a rural area are associated with physical inactivity among stroke survivors.

Study led by Mount Sinai researcher shows sotagliflozin is the only drug in its class to demonstrate these results ...

The challenges of translating neuroprotective interventions with promising efficacy in animal studies into effective treatments for patients with stroke are well documented, with issues including ...